The loss of body weight in ManLAM‐WT B group was significantly slower than that in ManLAM‐IL‐10−/− B group (Figure 2B), suggesting that IL‐10 produced by ManLAM‐treated WT B cells might attenuate the DSS‐induced acute colitis in mice. This evidence concerns the gene IL10 and colitis.